Published in Diabetes on June 01, 1995
Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest (2002) 4.73
Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med (2005) 4.04
A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med (2001) 3.03
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis (2007) 2.22
AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies. Cell (2016) 2.19
A genomic approach to human autoimmune diseases. Annu Rev Immunol (2010) 2.10
Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med (2006) 1.98
Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol (2010) 1.85
The role of dendritic cells in autoimmunity. Nat Rev Immunol (2013) 1.68
Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A (2008) 1.66
Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes (2009) 1.50
Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture. Diabetes (2008) 1.26
PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic β-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes (2011) 1.26
MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet (2010) 1.25
Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PLoS One (2013) 1.21
How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets. Immunol Rev (2008) 1.15
Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev (2008) 1.12
Histopathology of type 1 diabetes: old paradigms and new insights. Rev Diabet Stud (2009) 1.09
Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta. Clin Exp Immunol (2008) 1.07
Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease. Clin Diagn Lab Immunol (1999) 1.04
Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol (2010) 1.04
Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance. Arthritis Res Ther (2010) 1.03
STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc Natl Acad Sci U S A (2002) 1.02
Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol (2000) 1.00
Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release. J Clin Invest (1999) 1.00
USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis. Cell Death Dis (2012) 0.98
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes (2014) 0.98
Type 1 diabetes and interferon therapy: a nationwide survey in Japan. Diabetes Care (2011) 0.95
Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα. Proc Natl Acad Sci U S A (2013) 0.90
Diabetes and Hepatitis C: A Two-Way Association. Front Endocrinol (Lausanne) (2015) 0.89
B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice. J Immunol (2013) 0.88
Blocking type I interferon signaling rescues lymphocytes from oxidative stress, exhaustion, and apoptosis in a streptozotocin-induced mouse model of type I diabetes. Oxid Med Cell Longev (2013) 0.86
Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis. PLoS One (2011) 0.85
Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations. Front Immunol (2013) 0.85
Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodes. Am J Pathol (2011) 0.83
Viral infections in type 1 diabetes mellitus - why the β cells? Nat Rev Endocrinol (2016) 0.83
Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil. Clin Exp Immunol (2002) 0.83
Interferon therapy in hepatitis C leading to chronic type 1 diabetes. World J Gastroenterol (2015) 0.82
Reduction in ATP levels triggers immunoproteasome activation by the 11S (PA28) regulator during early antiviral response mediated by IFNβ in mouse pancreatic β-cells. PLoS One (2013) 0.82
Type I interferons mediate pancreatic toxicities of PERK inhibition. Proc Natl Acad Sci U S A (2015) 0.79
Immunoproteasome Activation During Early Antiviral Response in Mouse Pancreatic β-cells: New Insights into Auto-antigen Generation in Type I Diabetes? J Clin Cell Immunol (2013) 0.78
Rotavirus activates lymphocytes from non-obese diabetic mice by triggering toll-like receptor 7 signaling and interferon production in plasmacytoid dendritic cells. PLoS Pathog (2014) 0.78
Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells. Exp Diabetes Res (2009) 0.78
Safety, Tolerability, and Immunogenicity of Interferons. Pharmaceuticals (Basel) (2010) 0.75
Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling. Proc Natl Acad Sci U S A (2017) 0.75
Type-specific human papillomavirus detection in cervical smears in Romania. APMIS (2010) 0.75
Total chemical synthesis of human interferon alpha-2b via native chemical ligation. J Pept Sci (2015) 0.75
Targeting Innate Immunity for Type 1 Diabetes Prevention. Curr Diab Rep (2017) 0.75
Type 1 Interferons Potentiate Human CD8(+) T Cell Cytotoxicity Through a STAT4 and Granzyme B Dependent Pathway. Diabetes (2017) 0.75
Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment. Front Endocrinol (Lausanne) (2017) 0.75
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med (1993) 17.01
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91
Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature (1998) 7.43
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell (1984) 6.71
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature (1998) 6.49
The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature (1996) 5.69
Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet (1983) 5.64
Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet (1983) 3.85
Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell (1986) 3.70
Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol (1985) 3.18
IGF-I is required for normal embryonic growth in mice. Genes Dev (1993) 3.17
An inherited limb deformity created by insertional mutagenesis in a transgenic mouse. Nature (1985) 3.05
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry (2002) 3.01
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (1987) 2.96
The human beta-globin gene and a functional viral thymidine kinase gene in developing mice. Proc Natl Acad Sci U S A (1981) 2.93
Characterization of a multicomponent receptor for GDNF. Nature (1996) 2.92
Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med (1993) 2.88
Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age. Diabetologia (1999) 2.81
Parental legacy determines methylation and expression of an autosomal transgene: a molecular mechanism for parental imprinting. Cell (1987) 2.78
Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell (1988) 2.70
The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia (1974) 2.69
A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest (1999) 2.65
Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (1982) 2.58
Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature (1995) 2.54
Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes (2001) 2.51
Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med (1996) 2.40
Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest (2001) 2.35
Rapid mapping of protein functional epitopes by combinatorial alanine scanning. Proc Natl Acad Sci U S A (2000) 2.24
Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry (2001) 2.17
Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 2.15
RIP3, a novel apoptosis-inducing kinase. J Biol Chem (1999) 2.15
Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med (1990) 2.12
A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet (1995) 2.10
A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia (1994) 2.03
Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell (1995) 1.99
HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature (1983) 1.99
Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science (2000) 1.95
An efficient route to human bispecific IgG. Nat Biotechnol (1998) 1.93
Expression of murine H-2Kb histocompatibility antigen in cells transformed with cloned H-2 genes. Nature (1982) 1.91
A regulator of transcriptional elongation controls vertebrate neuronal development. Nature (2000) 1.87
Genetic dissection of autoimmune type I diabetes in the BB rat. Nat Genet (1992) 1.87
Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes (1988) 1.85
Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes (1996) 1.85
Organ-specific autoimmunity: a 1986 overview. Immunol Rev (1986) 1.84
FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine (1999) 1.83
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
The pancreatic beta-cell recognition of insulin secretagogues. Effects of calcium and sodium on glucose metabolism and insulin release. Biochem J (1974) 1.76
Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci (1999) 1.74
I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci U S A (1996) 1.74
The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia (2000) 1.74
Family cell lines available for research. Am J Hum Genet (1990) 1.72
Development of noradrenergic neurons in the zebrafish hindbrain requires BMP, FGF8, and the homeodomain protein soulless/Phox2a. Neuron (1999) 1.65
Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1. Neuron (1997) 1.65
Prenatal lethalities in mice homozygous for human growth hormone gene sequences integrated in the germ line. Cell (1983) 1.63
Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab (1998) 1.63
Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol (2001) 1.61
Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol (1994) 1.60
Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med (1978) 1.59
Selection for genes encoding secreted proteins and receptors. Proc Natl Acad Sci U S A (1996) 1.58
Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med (1997) 1.55
Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic beta-cells. J Biol Chem (1999) 1.53
Free radical activity and lipid soluble anti-oxidant vitamin status in patients with long-term ileal pouch-anal anastomosis. Colorectal Dis (2008) 1.53
Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am J Pathol (2001) 1.52
Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods (1995) 1.51
Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. J Biol Chem (1978) 1.51
Preparation and characterization of plasma membrane-enriched fractions from rat pancreatic islets. J Cell Biol (1976) 1.50
Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry (1994) 1.49
Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest (1996) 1.49
Prognostic factors for the course of beta cell function in autoimmune diabetes. J Clin Endocrinol Metab (2000) 1.48
Human islet cell transplantation--future prospects. Diabet Med (2001) 1.47
Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. Am J Pathol (1989) 1.47
Transcription and promoter usage of the myc gene in normal somatic and spermatogenic cells. Science (1984) 1.45
Human cell lines from families available for diabetes research. Diabetologia (1991) 1.44
Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP. Ann Oncol (1992) 1.42
Porcine islet isolation: prospective comparison of automated and manual methods of pancreatic collagenase digestion. Br J Surg (1993) 1.42
The effect of varying fibronectin concentration on the attachment of endothelial cells to polytetrafluoroethylene vascular grafts. J Vasc Surg (1990) 1.40
Awareness and the use of nutritional supplementation for age-related macular degeneration patients. Eye (Lond) (2007) 1.40
Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol (1986) 1.39
Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243. Diabetologia (1996) 1.38
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index. Diabetologia (1999) 1.37
The pancreatic beta-cell recognition of insulin secretogogues. Influence of neuraminidase treatment on the release of insulin and the islet content of insulin, sialic acid, and cyclic adenosine 3':5'-monophosphate. J Biol Chem (1974) 1.35
Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol (1998) 1.34
Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest (1995) 1.33
Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci U S A (1991) 1.33
Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia (1988) 1.32
Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science (1984) 1.31
Human class II major histocompatibility antigen beta-chains are derived from at least three loci. Nature (1983) 1.29
Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice. Diabetologia (2009) 1.27
Retrovirus-like sequences in Graves' disease: implications for human autoimmunity. Lancet (1989) 1.26
Lectin-induced expression of DR antigen on human cultured follicular thyroid cells. Nature (1983) 1.25
Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement. Diabetes (1981) 1.25
Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J Immunol (1998) 1.24
The pancreatic beta-cell recognition of insulin secretagogues: does cyclic AMP mediate the effect of glucose? Proc Natl Acad Sci U S A (1974) 1.24
Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments. Radiother Oncol (1992) 1.24
mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J Biol Chem (1999) 1.22
[Isolated mouse islets as a model for studying insulin release]. Acta Diabetol Lat (1972) 1.21
The pancreatic beta-cell recognition of insulin secretagogues. Comparisons of glucose with glyceraldehyde isomers and dihydroxyacetone. Arch Biochem Biophys (1974) 1.20
The hypogonadal mouse: reproductive functions restored by gene therapy. Science (1986) 1.20